Skip to main content

Laura Ensign

NIH Rank #1247
  • R01 Holder
  • Top 10% Funded
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 11802366Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Ophthalmology
  • Internal Medicine

NIH Funding · FY2024

Linked Award Amount
$4.7M
Full award amounts, FY2024
Award Records
8
Records listing this PI
Award-Linked Rank
#1,247
By linked amount among FY2024 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Laura Ensign. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2024 award records by amount

NIH award records listing Laura Ensign as a PI. Multi-PI records show the full award amount for context.

  • 5R44EY035177-02R44
    Pharmaceutical development of longer-lasting brimonidine eye drops
    $964.5K
    award amount
  • 5U24EY035078-02U24
    Development of standardized resources for characterization of the resident ocular surface microbiome.
    $876.6K
    award amount
  • 5R01HD103124-04R01
    Nanomedicine approaches for prevention of inflammation-induced preterm birth
    $623.4K
    award amount
  • 5R01HD108905-02R01
    Nanomedicine-based approach for characterizing the epigenome in prevention of inflammation-induced preterm birth.
    $602.4K
    award amount
  • 1R01EY034902-01A1R01
    Topical drug delivery formulations for neuroprotection in glaucoma
    $539.2K
    award amount
  • 5R01EY033386-03R01
    Eye drop formulations for enhanced penetration of water soluble antibiotics to treat infections
    $471.4K
    award amount
  • 1R01EY036027-01R01
    Topical delivery of HIF-1 inhibitors for retinal and choroidal vascular diseases
    $436.7K
    award amount
  • 3U24EY035078-01S1U24
    Development of standardized resources for characterization of the resident ocular surface microbiome.
    $145K
    award amount

Award organizations

Organizations that administered FY2024 awards listing Laura Ensign as a PI.

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Johns Hopkins University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #1247
  6. 2024
    Entered Top 25% Nationally
    Ranked #1247
  7. 2024
    Entered Top 10% Nationally
    Ranked #1247
  8. 2025
    $5M Cumulative Funding
  9. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  10. 2025
    R01 Grant Holder